Font Size: a A A

Studies On Estradiol Nasal Spray

Posted on:2006-10-19Degree:MasterType:Thesis
Country:ChinaCandidate:W LengFull Text:PDF
GTID:2144360185988973Subject:Pharmacy
Abstract/Summary:PDF Full Text Request
Estradiol (E2) is a nature sex steroids hormone, used to improve the symptom of menopause, reduce the risk of bone fractures occurring after menopause, prevent and cure femme ovarian dysfunction primarily or after ovariectomy. The most common forms of E2 supplementation currently used are the oral, transdermal and provagina. However, the three methods have several limitations, respectively. In order to avoid the first pass effect and elevate the bioavailability of E2, and improve the compliance of the patients, the E2 nasal spray was prepared.The HPLC method was established to determine the E2 concentration in E2 nasal spray and the solubility in different medium. The character of E2 was investigated, too.E2 is a lipid soluble drug which is micromolecular, if wanted to nasal administration, its solubility in water must be increased, so the randomly methylatedβ-cyclodextrin (RAMEB) complex was prepared to develop the solubility in water. The preparation method was studied with factor investigation, based on which, the solubility of E2 in water and entraption ratio were taken as indexes to optimize the preparation technology with orthogonal design experiment. Finally determined the optimal technology. The complex prepared by this technology had the better solubility in water and better physical stability. The complex was identified by DSC and X- ray diffraction method. Rat in situ nasal perfusion methods was used as an experimental model to investigate the regulation of nasal absorption. The effects of perfusion volume, flow rate, and perfusion concentration on nasal absorption of E2 were studied. The results were that the larger the perfusion volume was, the less of the percent absorbed was each minute. The faster the flow rate was, the more of the percent absorbed each minute. The mechanism of E2 nasal absorption is active transport, following zero-order kinetics.By rat in situ nasal perfusion methods, the optimal amount of chitosan bolted was 0.5 %; and the influence of the formulation pH on the E2 nasal absorption was investigated, the results indicated that in the pH range of 4.0-6.0, there was no influence on the E2 nasal absorption.After Making sure the stable pH range of the E2 nasal spray, the influential factor study and initial stability investigation were carried out, the results indicated the stable pH range was 4.0~6.0; the formulation was stable to heat and light; and had good stability in accelerated test within 3 months and long-term place test within 4 months.To assess the nasal ciliary toxicity of E2 nasal spray, the hoptoad in situ maxilla mucosa method was used by determining the ciliary movement time after in. administration. The toxicity is very little and the preparation can be used in nasal delivery system. Based on the researches above, the dosage form of E2 nasal spray were: the complex was prepared with E2 and RAMEB in 1:2(mol ratio), the dosage of chitosan and benzalkonium chloride was 0.5% and 0.01%, respectively, sodium chloride was used to adjust iso-osmia, pH range was 4.0~6.0.HPLC fluorometric method was performed to detect the concentration of E2 in rats plasma, which was simple and precise. Physical solution of the E2-RAMEB combination, and 70% ethanol solution of E2 and E2 nasal spray in 3 different doses (0.16,0.48,1.60 mg·Kg-1) had been nasally administrated to rats, respectively. Non-compartment statistical moment method had been used in pharmacokinetics study. Absolute bioavailability degree had been compared with E2 i.v. Tmax, Cmax values and absolute bioavailability degree of groupⅠ(E2 nasal spray 0.16,0.48,1.60 mg·Kg-1),Ⅱ(Physical solution of the E2-RAMEB combination),Ⅲ(70% ethanol solution of E2) are 30, 25, 13, 20 and 5 min; 72.41, 74.72, 259.21, 20.51 and 60.65 ng·ml-1; 86.87%, 65.83%, 48.99%, 56.44% and 24.38%, respectively. Absolute bioavailability degree of both 0.16和0.48 mg.kg-1 administration in groupⅠare higher than that in groupⅡ, which showed nasal spray enhanced medicine absorption compared with combination solution.HPLC fluorometric method was performed to detect the concentration of E2 in rats CSF, which was simple and precise. E2 concentration in CSF and plasma were examined, probe recovery was 61.64% by concentration difference method. Non-compartment statistical moment method had been used in pharmacokinetics study. Absolute bioavailability degree of test preparation had been compared with E2 i.v., Tmax, Cmax and AUC values in CSF of i.n. and i.v. administration were 20 and 60min; 37.05 and 17.91 ng·ml-1; 4445.74 and 3228.48 ng·min·ml-1, respectively. AUCCSF/AUCplasma value were 1.08 and 0.41, the results of t-test indicated the data was significant difference between the i.n. and i.v. administration(P<0.05). It was clear that E2 could directly enter brain through olfactory channel because of the shorter of Tmax, it implement with two pathway, this conclusion was conformity with the research before. The site of action and recipient of female hormone were in the central nervous system, this research supplied the evidence of E2 nasally administration to cure Alzheimer.
Keywords/Search Tags:estradiol, nasal administration, randomly methylated -cyclodextrin, saturated solution method, chitosan, in situ nasal perfusion method, nasal ciliary toxicity, pharmacokinetic, brain microdialysis
PDF Full Text Request
Related items